Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 691,192 |
|
|||||
| News | - | ||||||
| Day High | 6.30 | Low High |
|||||
| Day Low | 6.10 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MiMedx Group Inc | MDXG | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.13 | 2.11% | 6.29 | 16:15:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.11 | 6.10 | 6.30 | 6.29 | 6.16 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,032 | 691,192 | $ 6.17 | $ 4,265,632 | - | 3.31 - 9.27 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:20:00 | 39 | $ 6.29 | USD |
MiMedx Group Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 924.37M | 146.96M | - | 321.48M | 58.23M | 0.40 | 15.88 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MiMedx News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MDXG Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.58 | 6.62 | 6.10 | 6.30 | 584,630 | -0.29 | -4.41% |
| 1 Month | 8.17 | 8.17 | 6.10 | 7.06 | 819,693 | -1.88 | -23.01% |
| 3 Months | 8.16 | 9.0394 | 6.10 | 7.73 | 810,093 | -1.87 | -22.92% |
| 6 Months | 6.30 | 9.27 | 5.57 | 7.68 | 729,438 | -0.01 | -0.16% |
| 1 Year | 3.32 | 9.27 | 3.31 | 7.15 | 742,160 | 2.97 | 89.46% |
| 3 Years | 11.52 | 15.99 | 2.43 | 6.57 | 678,515 | -5.23 | -45.40% |
| 5 Years | 6.74 | 15.99 | 2.43 | 6.94 | 694,620 | -0.45 | -6.68% |
MiMedx Description
| MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, MiMedx sells allografts for ophthalmic surgery and dental applications through licenses to third parties. |
